Spinal Tech

InVivo Therapeutics added Philadelphia-based University of Pennsylvania as a clinical site for the INSPIRE study.

The global neurology devices market is anticipated to reach $10.8 billion by 2022, according to a Grand View Research report.

The first surgeries using Safe Orthopaedics' new SteriSpineCC range have been successfully completed.

Invibio signed a settlement agreement with the U.S. Federal Trade Commission to resolve antitrust allegations, according to a Mondaq report.

Xtant Medical CEO Daniel Goldberger bought 5,000 shares of the companies' stock, according to a Franklin Independent report.

A blog post from Amendia examines the top four changes in outpatient spine surgery.

TranS1 continues to build around its core product, AxiaLIF, acquired from Baxano. The technology is designed for surgeons to perform L5-S1 spinal fusions without removing the facet joints and destabilizing the spine.

From 2013 to 2019, the global sports medicine devices market is expected to grow at a compound annual growth rate of 4.4 percent.

Mazor Robotics released its earnings report for the first quarter of 2016.

BioTras launched AsTris 1.0 Spine Simulator at the recently-held 18th annual American Society of Interventional Pain Physicians conference in Dallas.